Close

CTSH

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

CTSH (Cathepsin H) is a Protein Coding gene. Diseases associated with CTSH include Thyroid Crisis and Intermittent Explosive Disorder. Among its related pathways are Innate Immune System and Surfactant metabolism. Gene Ontology (GO) annotations related to this gene include protein complex binding and peptidase activity. An important paralog of this gene is CTSK.
  • CAR Vector Products

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-CQ0683 Anti-CTSH (CBXC-1488) h(41BB-CD3ζ) CAR, pCDCAR1 Mouse CBXC-1488 Rat scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ0684 Anti-CTSH (CBXC-0618) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBXC-0618 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ0685 Anti-CTSH (AF14D7) h(41BB-CD3ζ) CAR, pCDCAR1 Human, Rat AF14D7 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ4107 Anti-CTSH (CBXC-1488) h(CD28-CD3ζ) CAR, pCDCAR1 Mouse CBXC-1488 Rat scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ4108 Anti-CTSH (CBXC-0618) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBXC-0618 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-CQ4109 Anti-CTSH (AF14D7) h(CD28-CD3ζ) CAR, pCDCAR1 Human, Rat AF14D7 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY3032 Anti-CTSH (CBFYC-2450) h(41BB-CD3ζ) CAR, pCDCAR1 Mouse CBFYC-2450 Rat scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WFY6285 Anti-CTSH (CBFYC-2450) h(CD28-CD3ζ) CAR, pCDCAR1 Mouse CBFYC-2450 Rat scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ0700 Anti-CTSH (CBWJC-3424) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBWJC-3424 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ0701 Anti-CTSH (AF14D7) h(41BB-CD3ζ) CAR, pCDCAR1 AF14D7 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ0702 Anti-CTSH (CBWJC-3425) h(41BB-CD3ζ) CAR, pCDCAR1 CBWJC-3425 Rabbit scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ0703 Anti-CTSH (CBWJC-3426) h(41BB-CD3ζ) CAR, pCDCAR1 Human CBWJC-3426 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ2992 Anti-CTSH (CBWJC-3424) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBWJC-3424 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ2993 Anti-CTSH (AF14D7) h(CD28-CD3ζ) CAR, pCDCAR1 AF14D7 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ2994 Anti-CTSH (CBWJC-3425) h(CD28-CD3ζ) CAR, pCDCAR1 CBWJC-3425 Rabbit scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-WJ2995 Anti-CTSH (CBWJC-3426) h(CD28-CD3ζ) CAR, pCDCAR1 Human CBWJC-3426 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.